{"id":"W4310126163","doi":"10.1182/blood-2022-162738","title":"Elranatamab in Combination with Daratumumab for Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 3 Magnetismm-5 Study Safety Lead-in Cohort","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Lenalidomide; Oncology; Internal medicine; Cohort; Refractory (planetary science); Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001075369,0.0002510016,0.0004417996,0.0002153698,0.0002721472,0.00002970467,0.0003081629,0.00006492835,0.0003027101],"category_scores_gemma":[0.0002718728,0.0001790141,0.0000549959,0.0006697958,0.00009431373,0.0001204335,0.0001173519,0.0007529506,0.000005369116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003468863,"about_ca_system_score_gemma":0.0002354654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001649609,"about_ca_topic_score_gemma":0.004403998,"domain_scores_codex":[0.9968168,0.0004132783,0.0005359609,0.0006730472,0.001126286,0.0004346048],"domain_scores_gemma":[0.9979403,0.0008330216,0.0001704854,0.000792564,0.0001711778,0.00009247091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0889956,0.04350357,0.8332185,0.00003162846,0.0003846319,0.0003936491,0.005931898,0.00006829276,0.001996213,0.000009202409,0.0007647318,0.02470206],"study_design_scores_gemma":[0.2977953,0.0237754,0.6673665,0.00008068851,0.000196975,0.00001264359,0.002783973,0.0006514437,0.0005312425,0.00001543464,0.006529746,0.0002606422],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911222,0.0001739158,0.00001677614,0.0004037611,0.00008824611,0.006606761,0.0006317458,0.00004508341,0.0009114957],"genre_scores_gemma":[0.9961435,0.00002805462,0.0001868662,0.0001094894,0.00005277529,0.0009434267,0.001402029,0.00007024188,0.001063662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2087997,"threshold_uncertainty_score":0.7299982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01625222232836121,"score_gpt":0.2780908681726396,"score_spread":0.2618386458442784,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}